BSX Q1 2023 Earnings — Boston Scientific Corporation Revenue & Financial Results | Market Cap Arena

BSXBoston Scientific Corporation

$105B

Q1 2023 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$3.4B+12.0% YoY

Gross Profit

$2.1B61.3% margin

Operating Income

$515M15.2% margin

Net Income

$314M9.3% margin

EPS (Diluted)

$0.21

QoQ Revenue Growth

+4.5%

Cash Flow

Operating Cash Flow

$190M

Free Cash Flow

$69M

Stock-Based Comp.

$55M

Balance Sheet

Total Assets

$32.9B

Total Liabilities

$14.8B

Stockholders' Equity

$17.9B

Cash & Equivalents

$570M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$3.4B	$3.0B	+12.0%
Gross Profit	$2.1B	$1.8B	+12.7%
Operating Income	$515M	$457M	+12.7%
Net Income	$314M	$111M	+182.9%

Revenue Segments

Cardiovascular

$2.1B62%

MedSurg

$1.3B38%

Geographic Segments

UNITED STATES

$2.0B59%

Non-US

$1.4B41%